Biovian has signed an agreement with a European biopharmaceutical company for contract development and manufacturing of a COVID-19 vaccine.
Biovian is looking forward to discussing joint efforts against COVID-19.
European Biotechnology has published their spring issue with a bioprocessing special. Biovian is one of the CDMOs presented with an editorial article.
Biovian has expanded its GMP Viral Vector contract development and manufacturing facilities.